Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
305.8 USD | +1.59% | -0.01% | +6.17% |
05-28 | US FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment | RE |
05-28 | Amgen's Rare-Disease Treatment Biosimilar Bkemv Gets FDA Approval | DJ |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bullish | Neutral | Bullish |
Resistance | 324.56 | 324.56 | 323.19 |
Spread/Res. | -5.78% | -5.78% | -5.38% |
Spread/Supp. | +6.81% | +16.38% | +15.23% |
Support | 286.30 | 262.75 | 265.39 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- AMGN Stock
- Charts Amgen Inc.